DONATE

Molecular Imaging for Precision Medicine

Group

IBEC researcher Irene Marco-Rius receives Anatole Abragam Prize for her contributions to the field of magnetic resonance

Dr Irene Marco-Rius, principal investigator at the Institute for Bioengineering of Catalonia (IBEC), has been awarded the 2025 Anatole Abragam Prize for her pioneering work on the use of magnetic resonance to study cells grown on chips, allowing ex vivo metabolic assessment of disease mechanisms and therapy responses in controlled microenvironments. The award was presented at the Joint ENC-ISMAR Conference in California.

IBEC and SJD Barcelona Children’s Hospital strengthen their collaboration with a day of translational innovation

The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.

Atomic sensors unveil hidden dynamics of molecular polarization

Researchers from IBEC and ICFO demonstrate the ability of atomic sensors to non-destructively monitor, measure and optimize nuclear spin hyperpolarization of some clinically relevant molecules in real-time. These features, reported in PNAS, could enhance and reduce costs of quality controls used in clinical magnetic resonance imaging.

Researcher Irene Marco Rius awarded prestigious European ERC Starting Grant

IBEC Principal Investigator Irene Marco Rius has been selected for the European Research Council (ERC) Starting Grant call to carry out her project ‘LIFETIME’. The project focuses on the study of individual cancer metabolism, which is crucial for less invasive early diagnosis and personalised treatments.

IBEC engages in two public-private partnerships for biomedical breakthroughs

IBEC and Vitala, a spin-off founded by IBEC researchers, are set to participate in three public-private partnership projects, with a combined investment nearing €4 million. These initiatives, backed by the Spanish Ministry of Science and Innovation and the State Research Agency, aim to advance remote health monitoring, create an oral drug for Inflammatory Bowel Disease, and enhance 13C magnetic resonance imaging for therapeutic research. Leveraging cutting-edge technological approaches, these endeavors aspire to make a positive impact on the fields of medicine and biomedical research.

Success at the conclusion of the 6th edition of the course “Mad for Bioengineering”

For the sixth consecutive year, IBEC has successfully hosted its ‘Mad for Bioengineering’ course with the support of the Catalunya La Pedrera Foundation. Geared towards 1st-year high school students interested in STEM careers, the program provides a unique immersion in the field of bioengineering, addressing health issues from a multidisciplinary perspective. The closing ceremony, attended by students and their families, featured presentations of final projects and the awarding of diplomas.

IBEC becomes the first research center in Spain to certify its laboratories as sustainable

IBEC’s Core Facilities and nine of its research groups have undergone the “green laboratory” certification process granted by the My Green Lab organization, all awarded with the highest levels of … Read more

IBEC researcher James Eills to meet with Nobel laureates

Dr. James Eills, researcher at IBEC, has been selected to attend the prestigious Lindau Nobel Laureate Meeting that brings together outstanding young scientists from around the world with Nobel laureates. This year, the event will be dedicated to Physiology & Medicine and will be held from 25th-30th June in Lindau, Germany.

Cookies
Cookie Consent The IBEC website uses cookies and similar technologies to ensure the basic functionality of the site and for statistical and optimisation purposes. It also uses cookies to display content such as YouTube videos that use marketing cookies. This last category consists of tracking cookies: these make it possible for your online behaviour to be tracked. You consent to this by clicking on Accept. Also read our Privacy statement. Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
Save Accept all